Award

Delivery Order #SPE2D226F1385

Delivery Order for Haloperidol Injection under Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$80.18

Ceiling

$80.18

Awarded

February 26, 2026

Period of Performance

Feb 26, 2026 – Feb 26, 2026

Identifier

SPE2D226F1385

NAICS

325411

This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor known for supplying essential medications to government agencies. The contract specifically pertains to the procurement of Haloperidol Injection, a critical pharmaceutical product. This delivery order is part of a broader indefinite delivery vehicle (IDV) contract previously awarded to DMS Pharmaceutical Group, which ensures a steady and reliable supply of a wide range of drug products crucial for government health services. The contract holds significant importance by supporting public healthcare systems in maintaining timely access to vital medications. The scope of this delivery order covers the provision of Haloperidol Injection, scheduled for fulfillment on a specified short-term timeline. This contract was awarded under an existing IDV agreement, which was competitively bid to promote sustained and efficient pharmaceutical supply. While detailed subcontractor information is not available for this delivery order, the overarching IDV contract exemplifies a substantial multi-year commitment to enhancing government healthcare capabilities.

Description

8511947817!HALOPERIDOL INJECTI

View original record